This text is a result of machine translation.
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Yesterday 09:00 AM
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs
IVD Company Health Genetech Bags Hundreds of Mns of CNY in Series C Round
Founded in 2011, Health Genetech, a medical test solution provider, focuses on clinical diagnosis and forensic science. It provides comprehensive medical test solutions covering molecular diagnosis, immuno-diagnosis and biochemical diagnosis for medical institutions and local disease control authorities as well as DNA-based human identification and kinship identification for public security and judicial institutions.
Yesterday 03:47 PM
WIM 2022: Transcript of Fireside Chat of Biotech [1/2]
EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.
Aug 05, 2022 09:11 PM
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
WIM 2022: Transcript of Fireside Chat of Biotech [2/2]
EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.
Aug 05, 2022 09:08 PM
Analysis of Pharmaceutical CRO Industry in China
With the rising demand of global drug R&D and the tightening policies about new drug development in China, contract research organization, also named CRO, captured a particular attention of Chinese pharmaceutical companies and investors. So, how to explain the popularity of the CRO industry in China? Why Chinese CRO companies like to go global? Will the digitalization of CRO services be a new trend in the future? After reading this article, you will know the answers above.
Aug 03, 2022 12:17 PM
East China medicine "liraglutide" goes to sea
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China